Hisamitsu Pharmaceutical : Earning Document

Hisamitsu Pharmaceutical Co., Inc.

Q2 FY02/2024 Results

This presentation material contains information that constitutes forward-looking statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ from those in the forward-looking statements as a result of various factors including changes in material circumstances.

Hisamitsu Pharmaceutical Co., Inc.

Oct. 6th, 2023

11

Agenda

1. Looking back on the Q2 FY02/2024
2. Promotion of Sustainability
3. Progress for FY02/2024
4. Consolidated P&L
5. Sales Results by Region
6. Sales Results by Product
7. Trends of second-generationnon-steroidalanti-inflammatory patch(Topical formulations) in Japan
8. Trends of non-steroidalanti-inflammatory drugs, (Systemic

formulations) Market Trend in Japan 9.R&D Pipeline

2

1. Looking back on the Q2 FY02/2024(1)

Rx Business

OTC Business

Mar. ・Notification of approval for manufacturing and marketing approval of APOHIDE® Lotion 20% in Japan (Primary palmar hyperhidrosis treatment drug, development code: HP-5070)

May. ・Notification of Launch of APOHIDE® Lotion 20% in Japan (Primary palmar hyperhidrosis treatment drug) Jun. ・Launch of APOHIDE® Lotion 20% in Japan (Primary palmar hyperhidrosis treatment drug)

Jun. ・Launch of TV commercial for primary palmar hyperhidrosis in Japan

Jun. ・"MOHRUS®TAPE 20mg″"MOHRUS®TAPE L40mg" Announcement of our wining 47th Kinoshita Prize for

"Packaging Technology"

Aug.・"MOHRUS®TAPE 20mg″"MOHRUS®TAPE L40mg" Announcement of our wining Optimum Packaging Award in Japan Packaging Contest 2023

Sep.19th Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)

Mar. ・Launch of "Feitas®Z Dicsas® ShippuF" 7 patches in Japan

Apr. ・Launch of "SALONPAS HOT®" 3 patches in Japan

Apr. ・Launch of Feitas® new TV Commercials in Japan

3

1. Looking back on the Q2 FY02/2024(2)

	Mar. ・The Minister of Economy, Trade and Industry Award at the 31st Global Environment Awards for
	the Kiyohara Industrial Park SmartEnergy Project
	Mar. ・Became an official partner of TEAM JAPAN (topical analgesic anti-inflammatory drugs,
	muscle fatigue care products, and medical supporters)
	Mar. ・JLPGA Step Up Tour "Salonpas Ladies Open" Newly Announced
	Mar. ・Establishment of a new research base at Shonan iPark
	Mar. ・Notice regarding Revision of Earnings Forecast
	May. ・Salonpas® certified as the World's No. 1 OTC topical analgesic patch brand for the 7th consecutive
	year since 2016
Others	Hisamitsu Pharmaceutical certified as the holder of the world's largest share in the corresponding
market category for the 6th consecutive year since 2017
	Jul. ・Conclusion of a contract with SSP Co., Ltd. for the partial transfer of assets, related to S-Cup and Lacalut
	Jul. ・Notice Regarding Company Split (Simplified Absorption-Type Split) with Hisamitsu Wellness Co., Ltd.
	Jul. ・Notification Regarding Concerning the Decision of MattersRelating to Acquisition of Company's Own Shares
	Jul. ・Notice regarding Issuance of Stock Compensation-Type Share Options(Stock Acquisition Rights)
	Jul. ・Providing Relief Supplies in Response to The Torrential Rains from July 7, 2023
	Jul. ・Finalized Stock compensation-type stock options (stock acquisition rights) issue details
	Aug. ・Products to solve issues for living in Space and living on Earth"Odorleship®"Notification to be used in
	the International Space Station

Sep.20th Notification regarding Skin Care Cosmetics with Microneedle Technology	4

1. Looking back on the Q2 FY02/2024(3)

APOHIDE®Lotion 20%, for the primary palmar hyperhidrosis treatment drug

Active ingredient :Oxybutynin hydrochloride

Specification	:Oxybutynin hydrochloride 200 mg / 1 g
Indications	: Primary palmar hyperhidrosis

Dosage and administration

:Apply an appropriate amount to

both palms once a day before bedtime

June 1, 2023 - Information Site for Solving Sweaty Hands Problems Launched "MINNANO TENOASE " website.

Palmar Hyperhidrosis Explained／Symptom Check Sheet／

Medical institutions where you can consult／Voices of people suffering from sweaty hands etc.

https://www.hisamitsu.co.jp/tenoase/

5